S2 Genomics

Private

Livermore, CaliforniaHealthcare & Life Scienceshttps://s2genomics.com/

Last Round

Series A

Jan 23, 2024

Total Funding Raised

$16.28M

Company Overview

S2 Genomics is a life science tools company that provides automated tissue sample preparation systems for single-cell genomics and cell biology applications.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

automated sample prepsingle cell genomicsautomated tissue dissociatortissue dissociationsingle cell sample preplab automationsingle cell suspensionsingle nuclei suspensionlife science toolsbiotech equipmentlab consumablesbenchtop instrumentrazor and blade modelscRNA-SeqsnRNA-Seqoncology researchneuroscience research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

S2 Genomics Comps

Public and private peers based on sector, stage, and business model.

S2 Genomics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

S2 Genomics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Jan 23, 2024
Seed	Dec 11, 2019
Grant	Jun 26, 2018

View all Funding Rounds

S2 Genomics Investors

Notable investors and investment history

S2 Genomics investors
Investor	Rounds
HealthTech Capital	Seed
Research Corporation Technologies	Series A
NIH RADx	Grant
Life Science Angels	Seed
BroadOak Capital Partners	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 1, 2025
Monthly visitors grew 119% MoM, reaching 1.4K.
Mar 28, 2024
Grew 19% QoQ, from 26 to 31 employees.

View all signals

S2 Genomics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

S2 Genomics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about S2 Genomics's valuation, stock price, and market status.

Firmographic Details

HeadquartersLivermore, California

Employee Range6

Year Founded2016

Last FundingJan 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.